Follow

Submissions from 2020

Link

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study., Ghassan K Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S Paulson, Mitesh J Borad, David Gallinson, Adrian G Murphy, Do-Youn Oh, Efrat Dotan, Daniel V Catenacci, Eric Van Cutsem, Tao Ji, Christine F Lihou, Huiling Zhen, Luis Féliz, and Arndt Vogel

Link

A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma., Victor A Chow, Joseph G Rajendran, Darrell R Fisher, Frederick R Appelbaum, Ryan D Cassaday, Paul S Martin, Leona A Holmberg, Theodore A Gooley, Philip A Stevenson, John M Pagel, Damian J Green, Oliver W Press, and Ajay K Gopal

Link

The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma., Nathan H Fowler, Loretta Nastoupil, Sven De Vos, Mark Knapp, Ian W Flinn, Robert Chen, Ranjana H Advani, Sumeet Bhatia, Peter Martin, Raul Mena, Richard Eric Davis, Sattva S Neelapu, Karl Eckert, Jerry Ping, Melannie Co, Darrin M Beaupre, Jutta K Neuenburg, and M Lia Palomba

PDF

Blood test shows high accuracy in detecting stage I non-small cell lung cancer., Cherylle Goebel, Christopher L Louden, Robert McKenna, Osita Onugha, Andrew Wachtel, and Thomas Long

Link

Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders., Henry G Kaplan, Gregory S Calip, and Judith A Malmgren

Link

Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts, Brian Koffman, Anthony Mato, John C. Byrd, Alexey Danilov, Brad Hedrick, Chaitra Ujjani, Lindsey Roeker, Deborah M. Stephens, Matthew S. Davids, John M Pagel, and Mazyar Shadman

Link

Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies., Manuela Cristina Matesan, Darrell R Fisher, Roger Wong, Ajay K Gopal, Damian J Green, William Bensinger, Brenda Sandmaier, John Pagel, Johnnie Orozco, Oliver W Press, Ryan Cassaday, Michele Wanner, Eric Hutchinson, Sujit Pal, Carolyn Thostenton, and Joseph Rajendran

Link

Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL Registry., Anthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, John M Pagel, Danielle M Brander, Meghan Gutierrez, Karen Kadish, Brian Tomlinson, Reethi Iyengar, David Ipe, Sandhya Upasani, Carlos I Amaya-Chanaga, Murali Sundaram, Jennifer Han, Nick Giafis, and Jeff P Sharman

Link

Fertility Concerns and Access to Care for Stem Cell Transplant Candidates with Sickle Cell Disease., Adrienne D Mishkin, Markus Y Mapara, Michelle Barhaghi, and Ran Reshef

Link

Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)., Ruth Pettengell, Monika Długosz-Danecka, David Andorsky, David Belada, Pencho Georgiev, Donald Quick, Jack W Singer, Simran B Singh, Athanasios Pallis, Anton Egorov, and Gilles Salles

Link

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Gilles Salles, William G Wierda, Raquel Izumi, Veerendra Munugalavadla, Priti Patel, Min Hui Wang, Sofia Wong, and John C Byrd

PDF

A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia., Catherine C Smith, Mark J Levis, Olga Frankfurt, John M Pagel, Gail J Roboz, Richard M Stone, Eunice S Wang, Paul L Severson, Brian L West, Mai H Le, Sabine Kayser, Bao Lam, Henry H Hsu, Chao Zhang, Gideon Bollag, and Alexander E Perl

Submissions from 2019

PDF

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib., Farrukh T Awan, Anna Schuh, Jennifer R Brown, Richard R Furman, John M Pagel, Peter Hillmen, Deborah M Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn, Melanie M Frigault, Ahmed Hamdy, Raquel Izumi, Bolan Linghu, Priti Patel, Min Hui Wang, and John C Byrd

Link

Pituitary Apoplexy., Garni Barkhoudarian and Daniel F Kelly

Link

Long-term follow-up of the RESONATE™ phase 3 trial of ibrutinib versus ofatumumab., John C Byrd, Peter Hillmen, Susan O'Brien, Jacqueline C Barrientos, Nishitha M Reddy, Steven Coutre, Constantine S Tam, Stephen P Mulligan, Ulrich Jaeger, Paul M Barr, Richard R Furman, Thomas J Kipps, Patrick Thornton, Carol Moreno, Marco Montillo, John M Pagel, Jan A Burger, Jennifer A Woyach, Sandra Dai, Remus Vezan, Danelle F James, and Jennifer R Brown

Link

Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results., John C Byrd, William George Wierda, Anna Schuh, Stephen Devereux, Jorge M Chaves, Jennifer R Brown, Peter Hillmen, Peter Martin, Farrukh T Awan, Deborah M Stephens, Paolo Ghia, Jacqueline Barrientos, John M Pagel, Jennifer A Woyach, Kathleen Burke, Todd Covey, Michael Gulrajani, Ahmed Hamdy, Raquel Izumi, Melanie M Frigault, Priti Patel, Wayne Rothbaum, Min Hui Wang, Susan O'Brien, and Richard R Furman

Link

Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy., Victor A Chow, Ajay K Gopal, David G Maloney, Cameron J Turtle, Stephen D Smith, Chaitra S Ujjani, Mazyar Shadman, Ryan D Cassaday, Brian G Till, Yolanda D Tseng, Edus H Warren, Andrei R Shustov, Manoj P Menon, Sandra Bhark, Utkarsh H Acharya, Erin Mullane, Lindsay M Hannan, Jenna M Voutsinas, Ted A Gooley, and Ryan C Lynch

Link

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation., Jeffrey A Cohen, Laura E Baldassari, Harold L Atkins, J D Bowen, Christopher Bredeson, Paul A Carpenter, John R Corboy, Mark S Freedman, Linda M Griffith, Robert Lowsky, Navneet S Majhail, Paolo A Muraro, Richard A Nash, Marcelo C Pasquini, Stefanie Sarantopoulos, Bipin N Savani, Jan Storek, Keith M Sullivan, and George E Georges

Link

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia., Toby A Eyre, Lindsey E Roeker, Christopher P Fox, Satyen H Gohill, Renata Walewska, Harriet S Walter, Francesco Forconi, Angus Broom, Arvind Arumainathan, Danielle M Brander, John N Allan, Stephen J Schuster, Brian T Hill, Frederick Lansigan, Bruce D Cheson, Nicole Lamanna, Catherine C Coombs, Paul M Barr, Alan P Skarbnik, Mazyar Shadman, Chaitra S Ujjani, Laurie Pearson, John M Pagel, Ryan Jacobs, and Anthony R Mato

Link

Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia., Livia Hegerova, Fiona He, Nicole D Zantek, Gregory M Vercellotti, Shernan G Holtan, and Mark T Reding

Link

Case report of two siblings with type 2A von Willebrand disease involving a novel mutation within the calcium-binding site of the A2 domain of von Willebrand factor., Henry P Igid, Kyaw Z Thein, Michael Castine, and Donald P Quick

Link

Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data., Vera Ignjatovic, Philipp E Geyer, Krishnan K Palaniappan, Jessica E Chaaban, Gilbert S Omenn, Mark S Baker, Eric W Deutsch, and Jochen M Schwenk

Link

Granulocyte Colony-Stimulating Factors in Therapy-Related Myelodysplastic Syndrome and Acute Myeloid Leukemia., Henry G Kaplan, Judith A Malmgren, and Gregory S Calip

Link

ACG Clinical Guideline: Hereditary Hemochromatosis., Kris V Kowdley, Kyle E Brown, Joseph Ahn, and Vinay Sundaram

Link

Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma., Donald J Lucas, Jeremy Rubinstein, Ankush Gosain, Greg Tiao, Tim Head, J Nick Pratap, Regan Williams, Sara Helmig, James Geller, Max Langham, and Angela Trobaugh-Lotrario

Link

A Phase Ib study of isatuximab plus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma., Joseph Mikhael, Paul Richardson, Saad Z Usmani, Noopur Raje, William Bensinger, Chatchada Karanes, Frank Campana, Dheepak Kanagavel, Franck Dubin, Qianying Liu, Dorothée Semiond, and Kenneth Anderson

Link

Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review., Vincent A Pallazola, Rishi K Kapoor, Karan Kapoor, John W McEvoy, Roger S Blumenthal, and Ty J Gluckman

Link

Duvelisib for CLL/SLL and follicular non-Hodgkin lymphoma., Krish Patel, Alexey V Danilov, and John M Pagel

Link

Exploring a Future for PI3K Inhibitors in Chronic Lymphocytic Leukemia., Krish Patel and John M Pagel

Link

Impact of dosing frequency (once daily or twice daily) on patient adherence to oral targeted therapies for hematologic malignancies: a retrospective cohort study among managed care enrollees., Krish Patel, Vinjamuri S Sudhir, Shaum Kabadi, Joanna C Huang, Sanchita Porwal, Kushan Thakkar, and John M Pagel

Link

Apixaban-induced haematoma causing small bowel intussusception., Ariel P Santos, Jennifer M Rodriguez, and Grace Berry

Link

ELEVATE TN: Phase 3 Study of Acalabrutinib Combined with Obinutuzumab (O) or Alone Vs O Plus Chlorambucil (Clb) in Patients (Pts) with Treatment-Naive Chronic Lymphocytic Leukemia (CLL)., Jeff P Sharman, Versha Banerji, Laura Maria Fogliatto, Yair Herishanu, Talha Munir, Renata Walewska, George Follows, Karin Karlsson, Paolo Ghia, Gillian Corbett, Patricia Walker, Miklos Egyed, Wojciech Jurczak, Gilles Salles, Ann Janssens, Florence Cymbalista, William G Wierda, Steven Coutre, John M Pagel, Alan Skarbnik, Manali Kamdar, Jennifer Woyach, Raquel Izumi, Veerendra Munugalavadla, Priti Patel, Min Hui Wang, Sofia Wong, and John C Byrd

Link

Programmed Cell Death Receptor (PD-1) Ligand (PD-L1) expression in Philadelphia chromosome-negative myeloproliferative neoplasms., Jen-Chin Wang, Chi Chen, Ajay Kundra, Sreenath Kodali, Anita Pandey, Ching Wong, Tony Cheung, Vladimir Gotlieb, Gardith Joseph, and Sophia Tribie

Link

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study., Habte Yimer, Jason Melear, Edward Faber, William Bensinger, John M Burke, Mohit Narang, Don Stevens, Sriya Gunawardena, Yana Lutska, Keqin Qi, Jon Ukropec, Ming Qi, Thomas S Lin, and Robert M Rifkin

Link

Blood Is a Window into Health and Disease., James T Yurkovich and Leroy Hood

Submissions from 2018

Link

Physical activity and epigenetic biomarkers in maternal blood during pregnancy., Sylvia E Badon, Alyson J Littman, Kwun Chuen Gary Chan, Mahlet G Tadesse, Patricia L Stapleton, Theo K Bammler, Tanya K Sorensen, Michelle A Williams, and Daniel A Enquobahrie

PDF

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)., John C Byrd, Amy S Ruppert, Nyla A Heerema, Alese E Halvorson, Eva Hoke, Mitchell R Smith, John E Godwin, Stephen Couban, Todd A Fehniger, Michael J Thirman, Martin S Tallman, Frederick R Appelbaum, Richard M Stone, Sue Robinson, Julie E Chang, Sumithra J Mandrekar, and Richard A Larson

Link

Editorial Perspective., Jens R Chapman

Link

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms, Chi Chen, Anita Pandey, Ajay Kundra, Sreenath Kodali, Ching Wong, Tony W. Cheung, Vladimir K. Gotlieb, Gardith Joseph, Sophia Tribie, and Jen-Chin Wang

Link

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation., Livia Hegerova, Adam Bachan, Qing Cao, Huong X Vu, John Rogosheske, Mark T Reding, Claudio G Brunstein, Mukta Arora, Celalettin Ustun, Gregory M Vercellotti, and Veronika Bachanova

Link

Mindfulness-Based Interventions for Hematology and Oncology Patients with Pain., Denise Hess

Link

Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial., Anthony R Mato, Lindsey E Roeker, John N Allan, John M Pagel, Danielle M Brander, Brian T Hill, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Constantine S Tam, Sasanka Handunnetti, Ryan Jacobs, Frederick Lansigan, Erica Bhavsar, Paul M Barr, Mazyar Shadman, Alan P Skarbnik, Andre Goy, Douglas F Beach, Jakub Svoboda, Jeffrey J Pu, Alison R Sehgal, Clive S Zent, Hande H Tuncer, Stephen J Schuster, Peter V Pickens, Nirav N Shah, Joanna Rhodes, Chaitra S Ujjani, and Chadi Nabhan

Link

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials., Megan Othus, Elihu H Estey, Guillermo Garcia-Manero, Brent L Wood, Derek L Stirewalt, John E Godwin, James K Weick, Jeanne E Anderson, Frederick R Appelbaum, Harry P Erba, and Roland B Walter

Submissions from 2017

PDF

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease., John C Kash, Kathie-Anne Walters, Jason Kindrachuk, David Baxter, Kelsey Scherler, Krisztina B Janosko, Rick D Adams, Andrew S Herbert, Rebekah M James, Spencer W Stonier, Matthew J Memoli, John M Dye, Richard T Davey, Daniel S Chertow, and Jeffery K Taubenberger

PDF

A Journey of Educational Transformation and Organizational Improvement through Development of an Institutional Patient Blood Management Program, Robert Raggi, Karen Klein, Marci Swearingen, and Mark Domantay

Submissions from 2016

Link

Navigating your career path in pediatric hematology/oncology: On and off the beaten track., Patrick A Zweidler-McKay, Mary-Jane Staba Hogan, Rima Jubran, Vandy Black, Jacqueline Casillas, James Harper, Suman Malempati, Judith Margolin, Judy Felgenhauer, Kathleen M Sakamoto, Janet Franklin, Mona Shah, Nita Seibel, George Buchanan, Sarah R Vaiselbuh, Caroline Hastings, Joanne Hilden, and Linda C Stork